case_images: PMC10628586_01
case_images: CT scan findings on August 7, 2022. These scan images showed thickening and swelling of the colorectal wall, abdominal and pelvic effusion, and a blurred abdominal fat space.
case_images: j_biol-2022-0753-fig001.jpg
case_images: PMC10628586_01_j_biol-2022-0753-fig001.jpg
case_images: j_biol-2022-0753_fig_001
case_images: A CT scan was then performed, and the scan image showed that the colorectal wall was thickened and swelled; there was effusion in abdomen and pelvis, and abdominal fat space was blur (Figure 1).
case_images: CT scan images on September 7, 2022. After CHM treatment, the cecum and descending colon were normal, while there was a small effusion of blood in the abdominal cavity. There is an edematous thickening of the ascending and transverse colon.
case_images: j_biol-2022-0753-fig002.jpg
case_images: PMC10628586_01_j_biol-2022-0753-fig002.jpg
case_images: j_biol-2022-0753_fig_002
case_images: The cecum and descending colon were normal, while there was a small effusion of blood in the abdominal cavity (Figure 2).
case_images: Changes in WBC and neutrophil counts before and after CHM treatment. A line graph was drawn to illustrate the changes of cell counts before and after therapy. Severe myelosuppression was found on July 29. From August 2 to August 7, the cell counts increased rapidly and reached the peak on August 7; however, the symptoms of fever and diarrhea were not improved. After CHM treatment, the cell counts recovered on September 7.
case_images: j_biol-2022-0753-fig003.jpg
case_images: PMC10628586_01_j_biol-2022-0753-fig003.jpg
case_images: j_biol-2022-0753_fig_003
case_images: The changes in WBC and neutrophil counts before and after CHM treatment are shown in Figure 3.